Free Trial

Actuate Therapeutics (ACTU) Institutional Ownership

Actuate Therapeutics logo
$8.67 -0.23 (-2.58%)
(As of 11/20/2024 ET)

Institutional Ownership Changes (13F Filings) for Actuate Therapeutics (NASDAQ:ACTU)

Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$296.35K
Number of
Institutional Sellers
(last 12 months)
0
Get ACTU Insider Trade Alerts

Want to know when executives and insiders are buying or selling Actuate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Actuate Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/12/2024 Northwestern University27,778$207K0.2%N/A0.142%
10/29/2024 KG&L Capital Management LLC12,000$89K0.0%N/A0.061%
(Data available from 1/1/2016 forward)

ACTU Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ACTU shares?

During the previous two years, the following institutional investors and hedge funds held shares of Actuate Therapeutics shares: Northwestern University ($207K), KG&L Capital Management LLC ($89K).Learn more on ACTU's institutional investors.

Which institutional investors have been buying Actuate Therapeutics stock?

The following institutional investors have purchased Actuate Therapeutics stock in the last 24 months: Northwestern University ($27.78K), and KG&L Capital Management LLC ($12K).

How much institutional buying is happening at Actuate Therapeutics?

Institutional investors have bought a total of 39,778 shares in the last 24 months. This purchase volume represents approximately $296.35K in transactions.



This page (NASDAQ:ACTU) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners